Denali Therapeutics Inc., a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).
Denali Therapeutics Inc., a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).